<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ophthalmology Product Guide &#187; Dry Eye</title>
	<atom:link href="http://www.ophthalmologyproductguide.com/blog/tag/dry-eye/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.ophthalmologyproductguide.com/blog</link>
	<description>A comprehensive guide to ophthalmology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 12:36:57 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Alcon Buys Rights For Durezol and Zirgan</title>
		<link>http://www.ophthalmologyproductguide.com/blog/2010/01/28/alcon-buys-rights-for-durezol-and-zirgan/</link>
		<comments>http://www.ophthalmologyproductguide.com/blog/2010/01/28/alcon-buys-rights-for-durezol-and-zirgan/#comments</comments>
		<pubDate>Thu, 28 Jan 2010 05:07:18 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Dry Eye]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Alcon]]></category>
		<category><![CDATA[Durezol]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[ophthalmic corticosteroid]]></category>
		<category><![CDATA[Sirion Therapeutics]]></category>
		<category><![CDATA[Zirgan]]></category>

		<guid isPermaLink="false">http://www.ophthalmologyproductguide.com/blog/?p=201</guid>
		<description><![CDATA[Alcon has bought rights for and Zirgan from Sirion Therapeutics Inc. for an undisclosed amount. While Durezol is an ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, Zirgan is an antiviral for the treatment of corneal ulcers. Both products have been approved by the Food and Drug Administration.
Alcon said [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.ophthalmologyproductguide.com/blog/wp-content/uploads/2010/01/Durezol.png"><img class="alignright size-full wp-image-202" src="http://www.ophthalmologyproductguide.com/blog/wp-content/uploads/2010/01/Durezol.png" alt="Durezol" width="200" height="47" /></a>Alcon has bought rights for and Zirgan from Sirion Therapeutics Inc. for an undisclosed amount. While Durezol is an ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, Zirgan is an antiviral for the treatment of corneal ulcers. Both products have been approved by the Food and Drug Administration.</p>
<p>Alcon said it has acquired the global rights, excluding Latin America, for Zyclorin, which is being developed as a potential treatment for dry eyes and other diseases.</p>
<div style="overflow: hidden;width: 1px;height: 1px"><!--[if gte mso 9]&gt;  Normal 0   false false false        MicrosoftInternetExplorer4  &lt;![endif]--><!--[if gte mso 9]&gt;   &lt;![endif]--><!--[if !mso]&gt;<span class="mceItemObject"></span> &lt;!  st1\:*{behavior:url(#ieooui) } &#8211;> <!--[endif]--><!--  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-parent:""; 	margin:0in; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman"; 	mso-fareast-font-family:"Times New Roman";} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --><!--[if gte mso 10]&gt; &lt;!   /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:&quot;Table Normal&quot;; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-parent:&quot;&quot;; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin:0in; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:10.0pt; 	font-family:&quot;Times New Roman&quot;; 	mso-ansi-language:#0400; 	mso-fareast-language:#0400; 	mso-bidi-language:#0400;} --> <!--[endif]--></p>
<p class="MsoNormal">Alcon Buys Rights For Durezol and Zirgan</p>
<p class="MsoNormal">Alcon has bought rights for Durezol and Zirgan from Sirion Therapeutics Inc. for an undisclosed amount. While Durezol is an ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, Zirgan is an antiviral for the treatment of corneal ulcers. Both products have been approved by the Food and Drug Administration.</p>
<p class="MsoNormal">
<p class="MsoNormal">Alcon said it has acquired the global rights, excluding Latin America, for Zyclorin, which is being developed as a potential treatment for dry eyes and other diseases.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.ophthalmologyproductguide.com/blog/2010/01/28/alcon-buys-rights-for-durezol-and-zirgan/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study shows increased occurrence of dry eye in men aged 80 years or more</title>
		<link>http://www.ophthalmologyproductguide.com/blog/2009/07/08/study-shows-increased-occurrence-of-dry-eye-in-men-aged-80-years-or-more/</link>
		<comments>http://www.ophthalmologyproductguide.com/blog/2009/07/08/study-shows-increased-occurrence-of-dry-eye-in-men-aged-80-years-or-more/#comments</comments>
		<pubDate>Thu, 09 Jul 2009 03:45:41 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Dry Eye]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[benign prostatic hyperplasia]]></category>
		<category><![CDATA[High blood pressure]]></category>
		<category><![CDATA[irritability]]></category>
		<category><![CDATA[Physicians' Health Studies]]></category>
		<category><![CDATA[severe dryness]]></category>

		<guid isPermaLink="false">http://www.ophthalmologyproductguide.com/blog/2009/07/08/study-shows-increased-occurrence-of-dry-eye-in-men-aged-80-years-or-more/</guid>
		<description><![CDATA[A recent study conducted over 6,848 participants depicted that the occurrence of dry eye disease increased in men aged 80 years or more. High blood pressure, benign prostatic hyperplasia and the use of antidepressant raise the risk of the disease, the study conducted by Physicians&#8217; Health Studies found. Dry eye is the &#8220;presence of clinically [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.ophthalmologyproductguide.com/blog/wp-content/uploads/2009/07/phs.png" align="right" vspace="5" width="200" height="19" hspace="5" />A recent study conducted over 6,848 participants depicted that the occurrence of dry eye disease increased in men aged 80 years or more. High blood pressure, benign prostatic hyperplasia and the use of antidepressant raise the risk of the disease, the study conducted by Physicians&#8217; Health Studies found. Dry eye is the &#8220;presence of clinically diagnosed dry eye&#8221; or symptoms that included severe dryness or irritability.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ophthalmologyproductguide.com/blog/2009/07/08/study-shows-increased-occurrence-of-dry-eye-in-men-aged-80-years-or-more/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Low tear producing eyes may develop dry eye after LASIK</title>
		<link>http://www.ophthalmologyproductguide.com/blog/2008/08/07/low-tear-producing-eyes-may-develop-dry-eye-after-lasik/</link>
		<comments>http://www.ophthalmologyproductguide.com/blog/2008/08/07/low-tear-producing-eyes-may-develop-dry-eye-after-lasik/#comments</comments>
		<pubDate>Thu, 07 Aug 2008 18:59:49 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Dry Eye]]></category>
		<category><![CDATA[Refractive Disorders]]></category>
		<category><![CDATA[Refractive Surgery]]></category>
		<category><![CDATA[chronic]]></category>
		<category><![CDATA[eye surgery]]></category>
		<category><![CDATA[LASIK]]></category>
		<category><![CDATA[low tear]]></category>
		<category><![CDATA[near and far sightedness]]></category>
		<category><![CDATA[ophthalmologist]]></category>
		<category><![CDATA[Schepens Eye Research Institute]]></category>

		<guid isPermaLink="false">http://www.ophthalmologyproductguide.com/blog/2008/08/07/low-tear-producing-eyes-may-develop-dry-eye-after-lasik/</guid>
		<description><![CDATA[According to research by scientists at the Schepens Eye Research Institute, people with a certain low level of tear production have a higher probability of developing chronic dry eye syndrome after having undergone LASIK surgery. The laser refractive surgery is done to correct near- and far-sightedness. The study, published in Investigative Ophthalmology and Vision Science, [...]]]></description>
			<content:encoded><![CDATA[<p><img border="0" vspace="5" align="left" width="200" src="http://www.ophthalmologyproductguide.com/blog/wp-content/uploads/2008/08/eye.gif" hspace="5" alt="eye" height="151" />According to research by scientists at the Schepens Eye Research Institute, people with a certain low level of tear production have a higher probability of developing chronic dry eye syndrome after having undergone LASIK surgery. The laser refractive surgery is done to correct near- and far-sightedness. The study, published in Investigative Ophthalmology and Vision Science, may help ophthalmologists find out if these patients require pretreatment and whether or not surgery is appropriate for such persons.</p>
<p><em><a href="http://www.flickr.com/photos/circo_de_invierno/2323786207/">Photo by circo de invierno</a></em></p>
]]></content:encoded>
			<wfw:commentRss>http://www.ophthalmologyproductguide.com/blog/2008/08/07/low-tear-producing-eyes-may-develop-dry-eye-after-lasik/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
